Rigel

Rigel drops asthma drug after mid-stage study fails
Reuters
Mon, 08/26/13 - 08:06 am
Rigel
asthma
R343
AstraZeneca Won’t Seek Approval for Rigel Arthritis Drug
Bloomberg
Tue, 06/4/13 - 10:25 am
Rigel
rheumatoid arthritis
AstraZeneca
fostamatinib
AstraZeneca, Rigel arthritis pill disappoints again
Reuters
Fri, 04/5/13 - 10:22 am
Rigel
AstraZeneca
fostamatinib
rheumatoid arthritis
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drug
Seeking Alpha
Thu, 12/20/12 - 10:40 am
Rigel
rheumatoid arthritis
fostamatinib
AstraZeneca
Hopes fade for AstraZeneca and Rigel's arthritis pill
Reuters
Thu, 12/13/12 - 11:05 am
Rigel
AstraZeneca
fostamatinib
Humira
Abbott Labs
rheumatoid arthritis
Rigel Announces Third Quarter 2012 Financial Results
Yahoo
Tue, 11/6/12 - 12:05 pm
Rigel
earnings
Rigel's Fostamatinib and the Future of Rheumatoid Arthritis Therapy
Yahoo/Reuters
Thu, 07/12/12 - 11:28 am
rheumatoid arthritis
Rigel
fostamatinib
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
Thu, 06/28/12 - 10:31 am
asthma
AstraZeneca
Rigel
JAK inhibitors
Amgen
GSK
JNJ
Eli Lilly
Merck
R256
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Biotech Calendar: Key Dates for October
TheStreet.com
Mon, 10/3/11 - 11:13 am
biotech
flurosorafenib
ONYX Pharmaceuticals
Bayer
Rigel
Teva Pharmaceuticals
Biogen Idec
BG-12
Heplisav
Amgen
Dynavax
Pacira
Bristol-Myers Squibb
Dapagliflozin
EXPAREL
cabozantinib
Exelixis
Rigel Refuels R&D in $130M Offering
Seeking Alpha
Sun, 05/29/11 - 12:47 pm
Rigel
fostamatinib
rheumatoid arthritis
AstraZeneca
R343
asthma
Rigel reports narrower 4Q loss, costs fall
Yahoo/AP
Tue, 03/1/11 - 11:01 am
Rigel
earnings
Pfizer, Incyte and Eli Lilly drug developments could transform future of rheumatoid arthritis therapy
FT.com
Mon, 11/29/10 - 12:44 pm
rheumatoid arthritis
Pfizer
Incyte
Eli Lilly
Rigel
JAK inhibitors
fostamatinib
Rigel Pharma earns $25M AstraZeneca payment tied to potential rheumatoid arthritis treatment
Yahoo/AP
Wed, 09/29/10 - 10:49 am
Rigel
AstraZeneca
milestone payments
rheumatoid arthritis
fostamatinib
AZ/Rigel RA drug hits PhIIb paydirt
Fierce Biotech
Thu, 09/23/10 - 09:45 am
Rigel
rheumatoid arthritis
AstraZeneca
Rigel posts 2Q net income on AstraZeneca payment
Yahoo/AP
Tue, 08/3/10 - 09:53 am
AstraZeneca
Rigel
earnings
Five high-value biotech stocks to watch
Fierce Biotech
Tue, 07/27/10 - 12:28 pm
Array Biopharma
Alnylam
Rigel
OncoGenex
Infinity
Waiting period ends for Rigel-AstraZenenca deal
Yahoo/AP
Mon, 03/29/10 - 10:54 am
AstraZeneca
Rigel
licensing
Was Rigel's $1.2B RA deal over-hyped?
Fierce Biotech
Mon, 02/22/10 - 03:30 pm
Rigel
partnerships
AstraZeneca
arthritis

Pages